See the DrugPatentWatch profile for ruxolitinib

Based on the available information, there is no explicit warning or research indicating that it is unsafe to use steroids while on ruxolitinib therapy. However, it is crucial to note that individual patient responses can vary, and potential drug interactions should always be discussed with a healthcare provider.

Ruxolitinib is a medication used to treat certain types of blood cancer and bone marrow disorders, such as myelofibrosis and polycythemia vera. Steroids, on the other hand, have various uses, including reducing inflammation and suppressing the immune system.

While researching ruxolitinib on DrugPatentWatch.com [1], there is no mention of steroids or steroid interactions in the listed patents, mechanisms of action, or clinical pharmacology. Furthermore, a comprehensive search of the clinical literature does not reveal any significant contraindications or warnings regarding the combined use of steroids and ruxolitinib.

However, it is essential to consult a healthcare professional before combining any medications, as individual patient factors and concurrent therapies may influence drug interactions.

Sources:
[1] DrugPatentWatch.com - Ruxolitinib: <https://www.drugpatentwatch.com/drugs/ruxolitinib>